Literature DB >> 30776799

Cardiovascular Disease Risk Estimation in China.

Paul K Whelton1, Lisandro D Colantonio2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30776799      PMCID： PMC6699934          DOI： 10.7326/M18-3301

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  8 in total

1.  Prevalence, awareness, treatment, and control of hypertension in china.

Authors:  Dongfeng Gu; Kristi Reynolds; Xigui Wu; Jing Chen; Xiufang Duan; Paul Muntner; Guanyong Huang; Robert F Reynolds; Shaoyong Su; Paul K Whelton; Jiang He
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

2.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; C Noel Bairey Merz; Conrad B Blum; Robert H Eckel; Anne C Goldberg; David Gordon; Daniel Levy; Donald M Lloyd-Jones; Patrick McBride; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Karol Watson; Peter W F Wilson; Karen M Eddleman; Nicole M Jarrett; Ken LaBresh; Lev Nevo; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli
Journal:  Circulation       Date:  2013-11-12       Impact factor: 29.690

3.  2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  David C Goff; Donald M Lloyd-Jones; Glen Bennett; Sean Coady; Ralph B D'Agostino; Raymond Gibbons; Philip Greenland; Daniel T Lackland; Daniel Levy; Christopher J O'Donnell; Jennifer G Robinson; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Paul Sorlie; Neil J Stone; Peter W F Wilson; Harmon S Jordan; Lev Nevo; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli
Journal:  Circulation       Date:  2013-11-12       Impact factor: 29.690

Review 4.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 10.190

5.  Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults.

Authors:  Yangfeng Wu; Xiaoqing Liu; Xian Li; Ying Li; Liancheng Zhao; Zuo Chen; Yihe Li; Xuxu Rao; Beifan Zhou; Robert Detrano; Kiang Liu
Journal:  Circulation       Date:  2006-11-06       Impact factor: 29.690

6.  Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement.

Authors:  Kirsten Bibbins-Domingo
Journal:  Ann Intern Med       Date:  2016-04-12       Impact factor: 25.391

7.  Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China).

Authors:  Xueli Yang; Jianxin Li; Dongsheng Hu; Jichun Chen; Ying Li; Jianfeng Huang; Xiaoqing Liu; Fangchao Liu; Jie Cao; Chong Shen; Ling Yu; Fanghong Lu; Xianping Wu; Liancheng Zhao; Xigui Wu; Dongfeng Gu
Journal:  Circulation       Date:  2016-09-28       Impact factor: 29.690

8.  Potential Cardiovascular Disease Events Prevented with Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline.

Authors:  Adam P Bress; Lisandro D Colantonio; Richard S Cooper; Holly Kramer; John N Booth; Michelle C Odden; Kirsten Bibbins-Domingo; Daichi Shimbo; Paul K Whelton; Emily B Levitan; George Howard; Brandon K Bellows; Dawn Kleindorfer; Monika M Safford; Paul Muntner; Andrew E Moran
Journal:  Circulation       Date:  2019-01-02       Impact factor: 29.690
  8 in total
  3 in total

Review 1.  Evolution of Blood Pressure Clinical Practice Guidelines: A Personal Perspective.

Authors:  Paul K Whelton
Journal:  Can J Cardiol       Date:  2019-02-27       Impact factor: 5.223

2.  Role of the N6-methyladenosine regulatory factor in reducing the risk of cardiovascular disease: subtype diagnosis following aerobic exercise-assisted weight loss.

Authors:  Xiaoya Hao; Yukun Li; Guo Huang; Ying Zeng
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

3.  Validating World Health Organization cardiovascular disease risk charts and optimizing risk assessment in China.

Authors:  Jianxin Li; Fangchao Liu; Xueli Yang; Jie Cao; Shufeng Chen; Jichun Chen; Keyong Huang; Chong Shen; Xiaoqing Liu; Ling Yu; Yingxin Zhao; Xianping Wu; Liancheng Zhao; Xigui Wu; Ying Li; Dongsheng Hu; Jianfeng Huang; Xiangfeng Lu
Journal:  Lancet Reg Health West Pac       Date:  2021-02-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.